LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.
Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...
Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...
Flovent, a corticosteroid treatment now sold under its generic name fluticasone propionate, was one of the most commonly prescribed pediatric asthma treatments, in particular because the inhaler ...
The two companies have already partnered to produce VR315, a generic version of GSK’s Advair/Seretide (fluticasone+salmeterol), and VR506, a generic, inhaled monotherapy for asthma. Vectura ...
Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...